Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Drug Resistance, Neoplasm
  • Lung Neoplasms
  • MAP Kinase Signaling System
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins B-raf
  • ras Proteins

publication date

  • May 2013

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1097/JTO.0b013e31828bb1b3

PubMed ID

  • 23524406

Additional Document Info

start page

  • e41

end page

  • 2

volume

  • 8

number

  • 5